Reply to Watkins and Rukazenkov (J Cell Mol Med 2010), re-Letter of Response to manuscript entitled ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14(1–2): 51–69)

Ejemplares similares

• Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69)
  por: Watkins, Claire, et al.
  Publicado: (2010)
• Cover (EMBO Mol. Med. 7/2013)
  Publicado: (2013)
• Masthead (EMBO Mol. Med. 7/2013)
  Publicado: (2013)
• Masthead (EMBO Mol. Med. 10/2013)
  Publicado: (2013)
• Masthead (EMBO Mol. Med. 9/2013)
  Publicado: (2013)